Interest in and Preference for Long-acting Injectable Antiretroviral Therapy in the Era of Approved Cabotegravir/Rilpivirine Among Reproductive-aged Women in the US South

被引：8

作者：

Collins, Lauren F. ^{[1
,2
]}

Sheth, Anandi N. ^{[1
,2
]}

Tisdale, Tina ^{[1
,2
]}

Mehta, C. Christina ^{[1
]}

Daniel, Gaea ^{[3
]}

Westreich, Daniel ^{[4
]}

Kassaye, Seble ^{[5
]}

Topper, Elizabeth F. ^{[6
]}

Konkle-Parker, Deborah ^{[7
]}

Rana, Aadia ^{[8
]}

Alcaide, Maria L. ^{[9
]}

Philbin, Morgan M. ^{[10
]}

机构：

[1] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA

[2] Ponce Leon Ctr, Grady Hlth Syst, Atlanta, GA USA

[3] Emory Univ, Nell Hodgson Woodruff Sch Nursing, Atlanta, GA USA

[4] Univ North Carolina Chapel Hill, Dept Epidemiol, Chapel Hill, NC USA

[5] Georgetown Univ, Dept Med, Washington, DC USA

[6] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA

[7] Univ Mississippi, Sch Nursing Med & Populat Hlth Sci, Med Ctr, Jackson, MS USA

[8] Univ Alabama Birmingham, Birmingham Heersink Sch Med, Dept Med, Div Infect Dis, Birmingham, AL USA

[9] Univ Miami, Miller Sch Med, Dept Med, Div Infect Dis, Miami, FL USA

[10] Univ Calif San Francisco, Dept Med, Div Vulnerable Populat, San Francisco, CA USA

来源：

CLINICAL INFECTIOUS DISEASES | 2024年 / 80卷 / 01期

基金：

美国国家卫生研究院;

关键词：

women with HIV; HIV and pregnancy; long-acting injectable antiretroviral therapy; cabotegravir/rilpivirine; southern HIV/AIDS epidemic; HIV;

D O I：

10.1093/cid/ciae331

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Among 103 reproductive-aged women with human immunodeficiency virus (HIV) in the US South surveyed post-approval of long-acting injectable (LAI) cabotegravir/rilpivirine, nearly two-thirds reported willingness to try LAI antiretroviral therapy (ART). Most expressed preference for LAI over daily oral ART and had minimal concerns over potential LAI-ART use impacting reproductive health.

引用

页码：164 / 167

页数：4

共 14 条

[1]

[Anonymous], Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States

[2] Centring the health of women across the HIV research continuum [J].

Barr, Elizabeth ;

Marshall, Leslie J. ;

Collins, Lauren F. ;

Godfrey, Catherine ;

St Vil, Noelle ;

Stockman, Jamila K. ;

Davey, Dvora L. Joseph ;

Dong, Krista ;

Temkin, Sarah M. ;

Glenshaw, Mary ;

Byrd, Corette ;

Clayton, Janine A. ;

Goodenow, Maureen M. .

LANCET HIV, 2024, 11 (03) :e186-e194

[3] Understanding Cross-Sectional Racial, Ethnic, and Gender Disparities in Antiretroviral Use and Viral Suppression Among HIV Patients in the United States [J].

Beer, Linda ;

Mattson, Christine L. ;

Bradley, Heather ;

Skarbinski, Jacek .

MEDICINE, 2016, 95 (13) :e3171

[4] Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy [J].

Benning, Lorie ;

Mantsios, Andrea ;

Kerrigan, Deanna ;

Coleman, Jenell S. ;

Golub, Elizabeth ;

Blackstock, Oni ;

Konkle-Parker, Deborah ;

Philbin, Morgan ;

Sheth, Anandi ;

Adimora, Adaora A. ;

Cohen, Mardge H. ;

Seidman, Dominika ;

Milam, Joel ;

Kassaye, Seble G. ;

Taylor, Tonya ;

Murray, Miranda .

BMC WOMENS HEALTH, 2020, 20 (01)

[5] The risks associated with stopping injectable antiretroviral treatment in women who are trying to conceive: a case series [J].

Coleman, Harry ;

Fox, Julie ;

Chilton, Daniella .

AIDS, 2022, 36 (08) :1205-1206

[6] Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 96-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study [J].

Jaeger, Hans ;

Overton, Edgar ;

Richmond, Gary ;

Rizzardini, Giuliano ;

Andrade-Villanueva, Jaime Federico ;

Mngqibisa, Rosie ;

Hermida, Antonio Ocampo ;

Thalme, Anders ;

Belonosova, Elena ;

Ajana, Faiza ;

Benn, Paul D. ;

Wang, Yuanyuan ;

Hudson, Krischan J. ;

Espanol, Carlos Martin ;

Ford, Susan L. ;

Crauwels, Herta ;

Margolis, David A. ;

Talarico, Christine L. ;

Smith, Kimberly Y. ;

van Eygen, Veerle ;

Van Solingen-Ristea, Rodica ;

Vanveggel, Simon ;

Spreen, William R. .

LANCET HIV, 2021, 8 (11) :E679-E689

[7] Likelihood of Trying Long-Acting Injectable Antiretroviral Therapy Among Women With HIV in Nine Sites Across the United States [J].

Mccrimmon, Tara ;

Collins, Lauren F. ;

Pereyra, Margaret ;

Platamone, Corbin ;

Perez-Brumer, Amaya ;

Shaffer, Victoria A. ;

Kerrigan, Deanna ;

Sheth, Anandi N. ;

Cohen, Mardge H. ;

Hanna, David B. ;

Ramirez, Catalina ;

Gange, Stephen J. ;

Rana, Aadia ;

Tamraz, Bani ;

Goparaju, Lakshmi ;

Wilson, Tracey E. ;

Alcaide, Maria ;

Philbin, Morgan M. .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2024, 96 (03) :e23-e27

[8]

Meade Christina M, 2019, Infect Dis Obstet Gynecol, V2019, P8161495, DOI 10.1155/2019/8161495

[9]

Orkin C, 2021, LANCET HIV, V8, pe185, DOI 10.1016/S2352-3018(20)30340-4

[10] Pregnancy outcomes and pharmacokinetics in pregnant women living with HIV exposed to long-acting cabotegravir and rilpivirine in clinical trials [J].

Patel, Parul ;

Ford, Susan L. ;

Baker, Mark ;

Meyer, Claudia ;

Garside, Louise ;

D'Amico, Ronald ;

Van Solingen-Ristea, Rodica ;

Crauwels, Herta ;

Polli, Joseph W. ;

Seal, Ciara ;

Yaguee Munoz, Itziar ;

Thiagarajah, Shanker ;

Birmingham, Eileen ;

Spreen, William R. ;

Baugh, Bryan ;

van Wyk, Jean ;

Vannappagari, Vani .

HIV MEDICINE, 2023, 24 (05) :568-579

← 1 2 →